Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Incruse price, strengths & recalls

Brand of umeclidinium (generic)

Pharmacies pay $11.30 for 1 inhaler of Incruse 0.0625 mg/actuation, 30 actuation inhaler (dry powder) this week, and from $10.27 to $11.30 across its 2 priced strengths and forms. The generic, umeclidinium, costs pharmacies from $7.26. Its official label last changed on May 20, 2026.

Brand
Pharmacies pay$11.30for 1 inhaler of 0.0625 mg/actuation, 30 actuation inhaler (dry powder)No change in 4 weeks
Fair cash price
$23.50
Strengths
2
Makers
1
Updated
Nov 11

Incruse price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.0625 mg/actuation, 30 actuation inhaler (dry powder) Brand$11.30$11.30 / 1 inhalerNo change-0.1%
0.0625 mg/actuation, 7 actuation inhaler (dry powder) Brand$10.27$10.27 / 1 inhalerNo change+0.2%

Incruse vs generic umeclidinium

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
0.0625 mg/actuation, 30 actuation inhaler (dry powder)$11.30$7.261.6x
GenericUmeclidinium prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for incruse? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMay 20, 2026
Version27 of 25
EffectiveDec 13, 2023
Read the label

These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA.INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation useInitial U.S. Approval: 2013

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA205382 · Glaxo Grp England
First approved
April 30, 2014 (12 years ago)
Latest approved change
December 13, 2023
Approved label
PDF, Dec 14, 2023
Generic makers
None on the market
Last patent listed
December 18, 2027

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Incruse questions

How much does incruse cost without insurance?

Pharmacies pay about $11.30 for 1 inhaler of incruse 0.0625 mg/actuation, 30 actuation inhaler (dry powder) ($11.30 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $23.50. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Incruse?

Yes: umeclidinium. Pharmacies pay from $7.26 for it. Compare umeclidinium prices.

Is incruse in shortage?

No shortage is reported for incruse right now. We check the national shortage list every day.

Has incruse been recalled?

No recalls are on record for incruse.

When did the incruse label last change?

The official label was last updated on May 20, 2026 (version 27). See what changed.

Talk about incruse

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.